rs78339727

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_020964.3(EPG5):​c.3248C>T​(p.Ser1083Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0294 in 1,596,020 control chromosomes in the GnomAD database, including 880 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1083S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.021 ( 59 hom., cov: 32)
Exomes 𝑓: 0.030 ( 821 hom. )

Consequence

EPG5
NM_020964.3 missense

Scores

1
8
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.89

Publications

11 publications found
Variant links:
Genes affected
EPG5 (HGNC:29331): (ectopic P-granules 5 autophagy tethering factor) This gene encodes a large coiled coil domain-containing protein that functions in autophagy during starvation conditions. Mutations in this gene cause Vici syndrome. [provided by RefSeq, Aug 2015]
EPG5 Gene-Disease associations (from GenCC):
  • Vici syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 18-45916574-G-A is Benign according to our data. Variant chr18-45916574-G-A is described in ClinVar as Benign. ClinVar VariationId is 466245.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0214 (3256/152170) while in subpopulation SAS AF = 0.0415 (200/4816). AF 95% confidence interval is 0.0368. There are 59 homozygotes in GnomAd4. There are 1606 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 59 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPG5NM_020964.3 linkc.3248C>T p.Ser1083Leu missense_variant Exon 18 of 44 ENST00000282041.11 NP_066015.2 Q9HCE0-1Q9BTI0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPG5ENST00000282041.11 linkc.3248C>T p.Ser1083Leu missense_variant Exon 18 of 44 1 NM_020964.3 ENSP00000282041.4 Q9HCE0-1

Frequencies

GnomAD3 genomes
AF:
0.0214
AC:
3258
AN:
152052
Hom.:
58
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00645
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.0242
Gnomad EAS
AF:
0.00251
Gnomad SAS
AF:
0.0415
Gnomad FIN
AF:
0.0363
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0307
Gnomad OTH
AF:
0.0144
GnomAD2 exomes
AF:
0.0266
AC:
6592
AN:
247554
AF XY:
0.0285
show subpopulations
Gnomad AFR exome
AF:
0.00525
Gnomad AMR exome
AF:
0.00735
Gnomad ASJ exome
AF:
0.0234
Gnomad EAS exome
AF:
0.00179
Gnomad FIN exome
AF:
0.0397
Gnomad NFE exome
AF:
0.0317
Gnomad OTH exome
AF:
0.0225
GnomAD4 exome
AF:
0.0302
AC:
43652
AN:
1443850
Hom.:
821
Cov.:
31
AF XY:
0.0311
AC XY:
22205
AN XY:
713888
show subpopulations
African (AFR)
AF:
0.00494
AC:
164
AN:
33174
American (AMR)
AF:
0.00735
AC:
326
AN:
44376
Ashkenazi Jewish (ASJ)
AF:
0.0241
AC:
625
AN:
25980
East Asian (EAS)
AF:
0.00322
AC:
126
AN:
39076
South Asian (SAS)
AF:
0.0487
AC:
4169
AN:
85638
European-Finnish (FIN)
AF:
0.0396
AC:
2108
AN:
53198
Middle Eastern (MID)
AF:
0.0199
AC:
114
AN:
5722
European-Non Finnish (NFE)
AF:
0.0314
AC:
34474
AN:
1097160
Other (OTH)
AF:
0.0260
AC:
1546
AN:
59526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1886
3772
5658
7544
9430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1320
2640
3960
5280
6600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0214
AC:
3256
AN:
152170
Hom.:
59
Cov.:
32
AF XY:
0.0216
AC XY:
1606
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.00643
AC:
267
AN:
41526
American (AMR)
AF:
0.0109
AC:
166
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0242
AC:
84
AN:
3468
East Asian (EAS)
AF:
0.00252
AC:
13
AN:
5168
South Asian (SAS)
AF:
0.0415
AC:
200
AN:
4816
European-Finnish (FIN)
AF:
0.0363
AC:
384
AN:
10592
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0307
AC:
2084
AN:
67992
Other (OTH)
AF:
0.0142
AC:
30
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
163
327
490
654
817
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0270
Hom.:
135
Bravo
AF:
0.0180
TwinsUK
AF:
0.0343
AC:
127
ALSPAC
AF:
0.0272
AC:
105
ESP6500AA
AF:
0.00665
AC:
27
ESP6500EA
AF:
0.0276
AC:
231
ExAC
AF:
0.0276
AC:
3339
Asia WGS
AF:
0.0160
AC:
55
AN:
3478
EpiCase
AF:
0.0305
EpiControl
AF:
0.0281

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Oct 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Vici syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.44
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.29
T;T
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.80
.;T
MetaRNN
Benign
0.0051
T;T
MetaSVM
Benign
-1.2
T
MutationAssessor
Uncertain
2.1
M;M
PhyloP100
3.9
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-3.5
D;.
REVEL
Benign
0.18
Sift
Uncertain
0.019
D;.
Sift4G
Uncertain
0.010
D;.
Polyphen
1.0
D;D
Vest4
0.13
MPC
0.15
ClinPred
0.017
T
GERP RS
5.8
Varity_R
0.096
gMVP
0.47
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.25
Position offset: -31

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78339727; hg19: chr18-43496539; COSMIC: COSV56348168; COSMIC: COSV56348168; API